000			02285 a2200733 4500
005			20250516175952.0
264		0	_c20131112
008			201311s 0 0 eng d
022			_a1533-4406
024	7		_a10.1056/NEJMoa1306494 _2doi
040			_aNLM _beng _cNLM
100	1		_aCortes, J E
245	0	0	_aA phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias. _h[electronic resource]
260			_bThe New England journal of medicine _cNov 2013
300			_a1783-96 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImidazoles _xadverse effects
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aProtein Kinase Inhibitors _xadverse effects
650	0	4	_aPyridazines _xadverse effects
650	0	4	_aThrombocytopenia _xchemically induced
650	0	4	_aThrombosis _xchemically induced
650	0	4	_aYoung Adult
700	1		_aKim, D-W
700	1		_aPinilla-Ibarz, J
700	1		_ale Coutre, P
700	1		_aPaquette, R
700	1		_aChuah, C
700	1		_aNicolini, F E
700	1		_aApperley, J F
700	1		_aKhoury, H J
700	1		_aTalpaz, M
700	1		_aDiPersio, J
700	1		_aDeAngelo, D J
700	1		_aAbruzzese, E
700	1		_aRea, D
700	1		_aBaccarani, M
700	1		_aMüller, M C
700	1		_aGambacorti-Passerini, C
700	1		_aWong, S
700	1		_aLustgarten, S
700	1		_aRivera, V M
700	1		_aClackson, T
700	1		_aTurner, C D
700	1		_aHaluska, F G
700	1		_aGuilhot, F
700	1		_aDeininger, M W
700	1		_aHochhaus, A
700	1		_aHughes, T
700	1		_aGoldman, J M
700	1		_aShah, N P
700	1		_aKantarjian, H
773	0		_tThe New England journal of medicine _gvol. 369 _gno. 19 _gp. 1783-96
856	4	0	_uhttps://doi.org/10.1056/NEJMoa1306494 _zAvailable from publisher's website
999			_c23221385 _d23221385